Apheresis Equipment Market Share to Outstrip $3.85 Billion, Globally, by 2028 with 8% CAGR – Growth Report by The Insight Partnership

The Insight Partners

The Insight Partners

The rising number of blood donors and the increasing incidence of hematologic disorders are driving global apheresis device market growth.

New York, Feb. 09, 2023 (GLOBE NEWSWIRE) — According to The Insight Partners, “Apheresis Equipment Market Size, Share, Revenue, Sales and Global Forecast to 2028 – Global Analysis by Product (Apheresis Machine and Disposable Apheresis Kits), Technology (Membrane Separation and Centrifugation), Procedure (Erythrocytapheresis, LDL-Apheresis, Leukapheresis, Photopheresis, Plasmapheresis, and Plateletpheresis), Therapeutic Area (Renal Diseases, Hematology, Neurology, and Other Applications), and End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Blood Donation Centers)”; the global apheresis equipment market size is expected to grow from USD 2.29 billion in 2021 to USD 3.85 billion in 2028; it is estimated to grow with a CAGR of 8% from 2022 to 2028.

Download PDF Brochure at https://www.theinsightpartners.com/sample/TIPHE100001288

Global Apheresis Equipment Market – Report Scope:

Market Size and Value

USD 2.29 Billion in 2021

Market Value

USD 3.85 Billion in 2028

Rate of growth

CAGR of 8.8% from 2022-2028

Forecast Period


Base Year


No. No.


No. No.


No. of Charts & Figures


Historical data available


Segments covered

End User

Apheresis Equipment Market – Competitive Landscape and Key Developments

Many small and large companies are involved in the apheresis market. Market players use a variety strategies to increase market shares, such as new product launches and regional expansion.

Medica SPA; Terumo Corporation; B. Braun Melsungen AG; Fresenius Medical Care AG & Co. KGaA; Asahi Kasei Corporation; Haemonetics Corporation; HemaCare Corporation; KANEKA MEDIX CORPORATION; Kawasumi Laboratories, Inc.; and medicap clinic GmbH are among the leading companies operating in the global apheresis equipment market. Companies adopt product innovation strategies to keep up with the changing customer needs globally.

Ask Before You Buy: https://www.theinsightpartners.com/inquiry/TIPHE100001288

Apheresis is a process in which blood is temporarily removed from the donor’s body and separated into various components such as plasma, platelets, red blood cells, and white blood cells by centrifugation or membrane separation process, depending on the components to be separated. Apheresis is used to remove impurities from blood and other abnormal components. It is a preferred method for controlling or curing diseases.

Apheresis Equipment Market Report highlights the main factors driving market growth as well as prominent players and their recent developments in the market. The market growth in apheresis is primarily due to the growing number of blood donors, rising incidences of hematologic disease, and aging population. Market growth is hindered by the high cost of apheresis devices and the complications involved in apheresis procedures. The market growth is expected to be aided by the growing popularity of apheresis in emerging countries.

Here are some of the most recent developments in the apheresis industry market.

March 2018TerumoBCT invested into Terumo Penpol (an Indian affiliate) to make it a leading production, research and innovation center around the world; this will allow India to become a major hub for blood management solutions.

In March 2018Haemonetics Corporation has received FDA approval for the NexSys PCS Platform. The system is incorporated with the Yes technology’s software, which has enhanced the plasma yield per collection. NextGen DMS (Donor Management System) has been launched by the company. This product improves the efficiency and effectiveness of plasma collection center operations.

Talk to a Research Expert https://www.theinsightpartners.com/speak-to-analyst/TIPHE100001288

Apheresis market growth will be fueled by the development of Therapeutic Apheresis

Therapeutic apheresis, an extracorporeal procedure that involves the removal of specific abnormal substances or cells from blood circulation, is used to treat various medical conditions. When other treatments have exhausted their limits, this technique aids in improving the medical process. Extracorporeal Photopheresis (ECP) is a process that is used for the treatment of a complication of bone marrow and stem cell transplants  and lymphoma. White blood cells (WBCs), are taken from the bloodstream and treated with light activated drugs. After that, they are exposed to UV for a final treatment. The therapeutic plasma exchange method is also a possible treatment for medical conditions like multiple sclerosis, myeloma and certain cases of leukemia. The technique withdraws plasma from the patient’s blood and replaces it with fresh donor plasma or bottled human albumin solution.

The advancement in healthcare has also allowed for the invention of plasma exchange and double filtration plasmapheresis. This technique can be used to treat rapidly progressive glomerulonephritis or low-density lipoprotein LDL apheresis. These two apheresis treatments are used to treat kidney disease. Apheresis market growth will be driven by the constant advancement in apheresis technologies that enhance the therapeutic process.

Purchase a Premium Copy of Apheresis Market Growth Report (2022-2028). https://www.theinsightpartners.com/buy/TIPHE100001288

The Middle East & Africa apheresis equipment market is segmented into the UAE, Saudi Arabia, and South Africa. Saudi Arabia held the largest share in the 2021 apheresis market. The market for apheresis equipment in the Middle East & Africa is anticipated to grow at a steady CAGR during the forecast period; this growth is attributed to the rising use of apheresis along with increasing incidences of renal disorders among the population. Patients in UAE hospitals have a wide acceptance of apheresis. The Sheikh Khalifa Medical City, one of the largest hospitals within the UAE, offers services for various blood disorders. The SKMC includes approximately 586 beds of tertiary care, 14 outpatient specialty clinics and the Abu Dhabi Blood Bank. The Abu Dhabi Blood Bank (ADBB), operated by the Sheikh Khalifa Medical City, increased  to 34067 in 2019 from 28,621 donors in 2018. The number of apheresis plates increased by 2,675 from 2017 to 2,799 for 2018. ADBB averages more than 250,000 units of blood per year and over 1,000 units of apheresis plateslets.

You can also view other research published in The Insight Partners’s portfolio:

Global Apheresis Market Size Forecast to 2028 – COVID-19 Impact Analysis and Global Analysis by Product (Apheresis Devices and Apheresis Appasis Software); Procedure, Automated Apheresis and Therapeutic Apheresis; Technology (Centrifugation and Membrane Separation); Application, Plasmapheresis and Plateletpheresis and Erythrocytapheresis and Leukapheresis and Other Applications); End Use (Blooooooooooood Centers and Hospitals and Others); and Geography

Global Blood Transfusion Devices Market Size Forecast to 2030 – COVID-19 Analysis and Global Analysis by Product ( infusion devices/blood warmers, filters, other devices) End User ( hospitals/ambulatory surgery centers/dialysis centers)

Global Leukapheresis Market Size Forecast to 2028 – COVID-19 Global Impact and Analysis by Product Type (Leukapheresis devices and Leukapheresis disposables), Application (Research Applications and Therapeutic Applications) and End User (Blood Component Providers and Blood Centers and Academic and Research Institutes. Pharmaceutical and Biotechnology Companies. Hospitals and Transfusion Centers.

Global Plasmapheresis Machines Market Size Forecast to 2028 – COVID-19 Impact and global Analysis. Type (Plasma Collector System, Multicomponent Collection Systems); Application (Extracorporeal Therapies, Plasma Donation), End User (Hospitals and Clinics; Ambulatory Surgical Centers; Blood Donation Centers);

Global Peristaltic Volumetric Pumps Market Size Forecast to 2028 – COVID-19 Global Analysis and Impact by Product (Mechanical speed Regulation and Frequency Regulation); End Use Hospitals, Ambulatory Surgical Centres, Clinics and Other) and Geography

About us:
The Insight partners is a leading industry provider of actionable information. Our syndicated and consulting services allow us to assist our clients in obtaining solutions to their research needs. We offer specialized services in areas such as Semiconductor and Electronics and Aerospace and Defense.

Get in touch with us
Please contact us if you have any questions about this report.

Contact Person: Sameer Joshi
E-mail: [email protected]
Telefon: +1-646-491-9876
Press Release: https://www.theinsightpartners.com/pr/apheresis-equipment-market

Previous post Russell Westbrook buyout destinations
Next post McDonald’s Just Won the Second-Worst First Date Place